Skip to content

Comparison of patients with poor ovarian response included in the antagonist cycle during standard, dual and triple triggering in IVF outcomes

Comparison of patients with poor ovarian response included in the antagonist cycle during standard, dual and triple triggering in IVF outcomes

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230702058644N1
Enrollment
108
Registered
2023-08-12
Start date
2023-07-11
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. infertilefertility

Interventions

Intervention 1: Control group: Standard triggering via the injection of human gonadotropic hormone (hCG). Intervention 2: Intervention group 1: dual triggering via hCG and Decapeptyl. Intervention 3:

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
24 Years to 42 Years

Inclusion criteria

Inclusion criteria: informed consent to participate in the study Age between 24-42 years old Body mass index of 19-27 The presence of POR (AFCI <7, AMH <1.5) Eligibility of the patient for IVF The absence of uterine abnormalities

Exclusion criteria

Exclusion criteria: Hypothalamic dysfunctions in the patient diabetes mellitus liver diseases heart diseases renal diseases epilepsy metabolic disorders

Design outcomes

Primary

MeasureTime frame
The number of good quality embryos. Timepoint: 3 days after fertilization. Method of measurement: High-quality cleavage stage embryos will have six cells or greater on day 3 and less than 10% fragmentation and symmetric blastomeres, according to the Istanbul consensus workshop.

Secondary

MeasureTime frame
Number of retrieved oocytes. Timepoint: 36 hours after triggering. Method of measurement: All oocyte retrievals will be performed under transvaginal ultrasound guidance and will be counted using light microscopy.;The number of mature oocytes. Timepoint: 36 hours after triggering. Method of measurement: All oocyte retrievals will be performed under transvaginal ultrasound guidance and the number of mature oocytes will be counted using light microscopy.;The number of clinical pregnancies. Timepoint: the presence of gestation sac two weeks after a positive hCG blood test. Method of measurement: ultrasound scan.;Implantation rate. Timepoint: at 6–7 weeks of pregnancy. Method of measurement: Implantation rate is calculated from the number of gestational sacs with a visible fetal heart on ultrasound scan divided by the total number of transferred embryos.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAliyeh Ghasemzadeh

Tabriz University of Medical Sciences

alghasemzadeh@yahoo.co.uk+98 41 3177 1041

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026